QLTI Stock UPDATES Qlt Inc (QLTI) 5.88 08/02/2014 13:46:50

New Post Public Reply Private Reply Replies (0) Message Board

Aug 2, 2014 at 2:46 PM

Qlt Inc (QLTI) 5.88 $QLTI

QLT Inc. (QLTI) Soars: Stock Adds 7.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 7:51AM CDT
QLT Inc. (QLTI) was a big mover last session, as its shares rose nearly 8% on the day.

QLT Announces Publication in The Lancet of Phase 1b Data for QLT091001 in Leber Congenital Amaurosis Due to LRAT or RPE65 Mutations
GlobeNewswire - Mon Jul 14, 6:00AM CDT
QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company"

today announced the publication of data from its Phase 1b proof-of-concept trial of QLT091001 in subjects with Leber Congenital Amaurosis (LCA) due to inherited genetic mutations in retinal pigment epithelium (RPE65) or lecithin:retinol acyltransferase (LRAT) in The Lancet. The peer-reviewed journal article is available first in the online edition of The Lancet at www.thelancet.com. In the study, treatment for 7 days with oral QLT091001 demonstrated a restoration of clinically meaningful visual function in 11 of the 14 LCA patients, as measured by improvement in Goldmann Visual Fields (GVF) or visual acuity. Self-reported or parent-reported improvements in activities of daily living supported these findings.

Salix-Cosmo to Merge in Tax-Saving Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 09, 4:35PM CDT
Following the merger, the combined entity will be renamed Salix Pharmaceuticals, plc. (SLXP) with Salix becoming a wholly-owned subsidiary of Irish domiciled Cosmo Technologies.

INVESTOR ALERT: The Law Offices of Vincent Wong Investigates the Sale of Auxilium Pharmaceuticals Inc.: - AUXL
PR Newswire - Tue Jul 08, 4:04PM CDT
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Auxilium Pharmaceuticals Inc. (NasdaqGS: AUXL) ("Auxilium"

in connection with the sale of the Company to QLT Inc. (NasdaqGS: QLTI).

AUXILIUM PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Auxilium Pharmaceuticals Inc. Board of Directors in Connection With the Proposed Sale of the Company to QLT Inc.
Business Wire - Mon Jul 07, 5:15PM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Auxilium Pharmaceuticals Inc. ("Auxilium" or the "Company"

(NASDAQ:AUXL) for potential breaches of fiduciary duties in connection with the sale of the Company to QLT Inc. ("QLT"

in an all-stock deal valued at approximately $851 million. The Company's stockholders will only receive 3.1359 QLT shares for each share of Auxilium common stock they own. Ultimately, Auxilium shareholders will own 76 percent of the combined company, while QLT shareholders will own the remaining 24 percent. Auxilium will be re-incorporating to Canada.

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Auxilium Pharmaceuticals, Inc. in Connection with the Sale of the Company
Business Wire - Mon Jul 07, 6:00AM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Auxilium Pharmaceuticals, Inc. ("Auxilium" or the "Company"

(Nasdaq: AUXL) relating to the proposed acquisition by QLT, Inc. ("QLT"

.

The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, MannKind, Auxilium Pharmaceuticals, QLT and AbbVie
PR Newswire - Thu Jul 03, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Vertex Pharmaceuticals (Nasdaq:VRTX-Free Report), MannKind Corporation (Nasdaq:MNKD-Free Report), Auxilium Pharmaceuticals (Nasdaq:AUXL-Free Report), QLT Inc. (Nasdaq:QLTI-Free Report) and AbbVie (NYSE:ABBV-Free Report).

SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of Auxilium Pharmaceuticals Inc. In Connection With The Proposed Sale Of The Company To QLT Inc.
Business Wire - Wed Jul 02, 2:55PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the board of directors of Auxilium Pharmaceuticals Inc. ("Auxilium" or the "Company"

(NASDAQ: AUXL) relating to the proposed buyout of the Company by QLT Inc. ("QLT"

.

Biotech Stock Roundup: Vertex Jumps on Phase III Data, MannKind Scores FDA Approval - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Jul 02, 9:41AM CDT
Highlights last week include positive phase III data on Vertex's cystic fibrosis combination, FDA approval of MannKind's Afrezza and Auxilium's merger deal with QLT Inc.

Netflix and Twitter are big market movers
AP - Tue Jul 01, 3:22PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:

Dividends, Mergers, and Study Results - Analyst Notes on Pfizer, Gilead, Pacira, QLT and Agenus
PR Newswire - Tue Jul 01, 5:30AM CDT
Today, Analysts Review released its analysts' notes regarding Pfizer Inc. (NYSE: PFE), Gilead Sciences Inc. (NASDAQ: GILD), Pacira Pharmaceuticals Inc. (NASDAQ: PCRX), QLT Inc. (NASDAQ: QLTI) and Agenus Inc. (NASDAQ: AGEN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4298-100free.

INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Auxilium Pharmaceuticals Inc. and Its Board of Directors In Connection With the Sale of the Company to QLT Inc. -- AUXL
PR Newswire - Mon Jun 30, 12:30PM CDT
Levi & Korsinsky is investigating the Board of Directors of Auxilium Pharmaceuticals Inc. ("Auxilium" or "the Company"

(NasdaqGS: AUXL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to QLT Inc. (NasdaqGS: QLTI).

Newman Ferrara LLP Announces Investigation of Auxilium Pharmaceuticals, Inc.
Business Wire - Mon Jun 30, 9:23AM CDT
Newman Ferrara LLP has begun an investigation into potential claims against the board of directors of Auxilium Pharmaceuticals, Inc. ("Auxilium"

(NASDAQ:AUXL) concerning its proposed merger agreement with QLT Inc. (NASDAQ:QLT).

INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Auxilium Pharmaceuticals Inc. and Its Board of Directors In Connection With the Sale of the Company to QLT Inc.
Business Wire - Fri Jun 27, 6:36PM CDT
Levi & Korsinsky is investigating the Board of Directors of Auxilium Pharmaceuticals Inc. ("Auxilium" or "the Company"

(NasdaqGS:AUXL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to QLT Inc.(NasdaqGS:QLTI).

AUXILIUM PHARMACEUTICALS SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Auxilium Pharmaceuticals Inc. Over the Proposed Sale of the Company to QLT Inc.
PR Newswire - Fri Jun 27, 6:00PM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Auxilium Pharmaceuticals Inc. ("Auxilium" or the "Company"

(NASDAQ: AUXL) for potential breaches of fiduciary duties in connection with the sale of the Company to QLT Inc. ("QLT"

in an all-stock deal valued at approximately $851 million. The Company's stockholders will only receive 3.1359 QLT shares for each share of Auxilium common stock they own. Ultimately, Auxilium shareholders will own 76 percent of the combined company, while QLT shareholders will own the remaining 24 percent. Auxilium will be re-incorporating to Canada.

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Auxilium Pharmaceuticals, Inc. in Connection with the Sale of the Company- AUXL
PR Newswire - Fri Jun 27, 5:35PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Auxilium Pharmaceuticals, Inc. ("Auxilium" or the "Company"

(Nasdaq: AUXL) relating to the proposed acquisition by QLT, Inc. ("QLT"

.

Auxilium and QLT to Merge on Tax Saving Attractions - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 27, 11:10AM CDT
Auxilium (AUXL) and QLT (QLTI) will combine by year end.

Auxilium Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate the Merger with QLT Inc.
Business Wire - Fri Jun 27, 11:03AM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Auxilium Pharmaceuticals Inc. ("Auxilium"

(NasdaqGS: AUXL) concerning the definitive merger agreement with QLT Inc. Under the terms of the agreement, Auxilium shareholders will receive 3.1359 QLT shares per Auxilium share owned.

QLT (QLTI) is in Overbought Territory: What's Next? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jun 27, 8:28AM CDT
QLT (QLTI) is in Overbought Territory: What’s Next?

Auxilium Pharmaceuticals Inc Joins the Buyout Bonanza
Stephen D., Simpson,, The Motley Fool - Motley Fool - Fri Jun 27, 7:30AM CDT
Amidst high-profile deals like Pfizer 's pursuit of AstraZeneca , Actavis 's acquisition of Forest Labs , and Valeant 's pursuit of Allergan , it...

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Step Inside Henson's Creature Shop Magic in NYC

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Streamlined AI Video Analytics for Public Safety Unveiled

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Lick the Plate Hits 2,000 Shows with Clown Band

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Intus Bio Secures $2.7M for Colorectal Cancer Test

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Oil Markets Shift Focus: Pipelines Trump Drilling

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Crystal Risotti: Leading IT Compliance in Healthcare

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

XKL Delivers MediaLight for High-Speed Optical Transport

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Fermi's Founder Pushes for Board Overhaul: What's Next?

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...